- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 277/64 - Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Patent holdings for IPC class C07D 277/64
Total number of patents in this class: 474
10-year publication summary
51
|
48
|
49
|
25
|
38
|
24
|
34
|
29
|
38
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4886 |
16 |
EyePoint Pharmaceuticals, Inc. | 98 |
13 |
Antabio SAS | 23 |
9 |
The Regents of the University of Michigan | 4570 |
8 |
Rutgers, The State University of New Jersey | 1840 |
8 |
Janssen Pharmaceutica N.V. | 3625 |
7 |
FUJIFILM Corporation | 28467 |
7 |
President and Fellows of Harvard College | 5904 |
7 |
Avexxin AS | 49 |
7 |
CHDI Foundation, Inc. | 108 |
7 |
Escient Pharmaceuticals, Inc. | 37 |
6 |
Lighthouse Pharmaceuticals, Inc. | 11 |
6 |
Genentech, Inc. | 3864 |
5 |
The General Hospital Corporation | 4637 |
5 |
Takeda Pharmaceutical Company Limited | 2945 |
5 |
Genzyme Corporation | 1216 |
5 |
Gilead Sciences, Inc. | 1949 |
5 |
Jawaharlal Nehru Centre for Advanced Scientific Research | 85 |
5 |
King Faisal University | 821 |
5 |
Sun Pharma Advanced Research Company Ltd. | 200 |
5 |
Other owners | 333 |